Task 3.5
Radiolabelling of subsets of immune cells for tracking immune cells in vivo...
Description
In Task 3.5 we aim to develop new cell labelling techniques that allow radiolabelling of subsets of cells, providing a novel method to validate the in vivo signal of cell-specific tracers in WP4 (Tasks 4.2-4) and cell-based therapies in WP5. With the...
General Design
- Type
- Cohort study
- Start/End data collection
- not available
Organisations
Lead organisations
- EBERHARD KARLS UNIVERSITAET TUEBINGENGermanyhttps://uni-tuebingen.de/en/
- PFIZER LIMITEDUnited Kingdom of Great Britain and Northern Ireland (the)https://www.pfizer.com/
- STICHTING VUMC (P1)Netherlands (the)https://www.vumc.nl/
- TAKEDA DEVELOPMENT CENTRE EUROPE LTDUnited Kingdom of Great Britain and Northern Ireland (the)
- WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTERGermanyhttps://www.uni-muenster.de/en/
Networks
Part of networks...